Skip to main content

Prevention of group B streptococcal neonatal disease revisited. The DEVANI European project

Abstract

The purpose of this paper was to present the current knowledge on the prevention of group B streptococcus (GBS) neonatal infections and the status of prevention policies in European countries and to present the DEVANI pan-European program, launched in 2008. The aim of this program was to assess the GBS neonatal infection burden in Europe, to design a new vaccine to immunize neonates against GBS infections, to improve the laboratory performance for the diagnosis of GBS colonization and infection, and to improve the methods for the typing of GBS strains. The current guidelines for GBS prevention in different countries were ascertained and a picture of the burden before and after the instauration of prevention policies has been drawn. After the issue of the Centers for Disease Control and Prevention (CDC) guidelines, many European countries have adopted universal screening for the GBS colonization of pregnant women and intrapartum prophylaxis to colonized mothers. Nevertheless, some European countries continue advocating the risk factor approach to GBS prevention. Most European countries have implemented policies to prevent GBS neonatal infections and the burden of the disease has decreased during the last several years. Nevertheless, further steps are necessary in order to develop new strategies of prevention, to improve microbiological techniques to detect GBS colonization and infection, and to coordinate the prevention policies in the EU.

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Edwards MS, Baker CJ (2010) Streptococcus agalactiae (group B streptococcus). In: Mandell GL, Bennett JE, Dolin R (eds) Principles and practice of infectious diseases. Vol 2, 7th edn. Elsevier, Philadelphia, Chapter 202

    Google Scholar 

  2. 2.

    Edwards MS, Nizet V (2011) Group B streptococcal infections. In: Remington JS, Klein JO, Wilson CB, Nizet V, Maldonado YA (eds) Diseases of the fetus and newborn infant, 7th edn. Elsevier, Philadelphia, pp 419–469

    Chapter  Google Scholar 

  3. 3.

    Barcaite E, Bartusevicius A, Tameliene R, Kliucinskas M, Maleckiene L, Nadisauskiene R (2008) Prevalence of maternal group B streptococcal colonisation in European countries. Acta Obstet Gynecol Scand 87:260–271

    PubMed  Article  Google Scholar 

  4. 4.

    Stupak A, Kwaśniewska A, Semczuk M, Zdzienicka G, Malm A (2010) The colonization of women genital tract by Streptococcus agalactiae. Arch Perinatal Med 16:48–50

    Google Scholar 

  5. 5.

    Lin FYC, Weisman LE, Azimi P, Young AE, Chang K, Cielo M, Moyer P, Troendle JF, Schneerson R, Robbins JB (2011) Assessment of intrapartum antibiotic prophylaxis for the prevention of early-onset group B streptococcal disease. Pediatr Infect Dis J 30:759–763

    PubMed  Article  Google Scholar 

  6. 6.

    Koenig JM, Keenan WJ (2009) Group B streptococcus and early-onset sepsis in the era of maternal prophylaxis. Pediatr Clin North Am 56:689–708

    PubMed  Article  Google Scholar 

  7. 7.

    Verani JR, Schrag SJ (2010) Group B streptococcal disease in infants: progress in prevention and continued challenges. Clin Perinatol 37:375–392

    PubMed  Article  Google Scholar 

  8. 8.

    Stoll BJ, Hansen NI, Sánchez PJ, Faix RG, Poindexter BB, Van Meurs KP, Bizzarro MJ, Goldberg RN, Frantz ID 3rd, Hale EC, Shankaran S, Kennedy K, Carlo WA, Watterberg KL, Bell EF, Walsh MC, Schibler K, Laptook AR, Shane AL, Schrag SJ, Das A, Higgins RD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network (2011) Early onset neonatal sepsis: The burden of group B streptococcal and E. coli disease continues. Pediatrics 127:817–826

    PubMed  Article  Google Scholar 

  9. 9.

    Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, Hadler JL, Danila R, Cieslak PR, Schuchat A (2000) Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 342:15–20

    PubMed  Article  CAS  Google Scholar 

  10. 10.

    Jordan HT, Farley MM, Craig A, Mohle-Boetani J, Harrison LH, Petit S, Lynfield R, Thomas A, Zansky S, Gershman K, Albanese BA, Schaffner W, Schrag SJ; Active Bacterial Core Surveillance (ABCs)/Emerging Infections Program Network, CDC (2008) Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis. Pediatr Infect Dis J 27:1057–1064

    PubMed  Article  Google Scholar 

  11. 11.

    Centers for Disease Control and Prevention (CDC) (1996) Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention. MMWR Recomm Rep 45:1–24

    Google Scholar 

  12. 12.

    Verani JR, McGee L, Schrag SJ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC) (2010) Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC, 2010. MMWR Recomm Rep 59:1–32

    PubMed  Google Scholar 

  13. 13.

    Gibbs RS, Schrag S, Schuchat A (2004) Perinatal Infections due to group B streptococci. Obstet Gynecol 104:1062–1076

    PubMed  Article  Google Scholar 

  14. 14.

    Heath PT, Schuchat A (2007) Perinatal group B streptococcal disease. Best Pract Res Clin Obstet Gynaecol 21:411–424

    PubMed  Article  Google Scholar 

  15. 15.

    Ohlsson A, Shah VS (2009) Intrapartum antibiotics for known maternal Group B streptococcal colonization. Cochrane Database Syst Rev (3):CD007467

  16. 16.

    Bedford H, de Louvois J, Halket S, Peckham C, Hurley R, Harvey D (2001) Meningitis in infancy in England and Wales: follow up at age 5 years. BMJ 323:533–536

    PubMed  Article  CAS  Google Scholar 

  17. 17.

    Baker CJ, Barrett FF (1973) Transmission of group B streptococci among parturient women and their neonates. J Pediatr 83:919–925

    PubMed  Article  CAS  Google Scholar 

  18. 18.

    Boyer KM, Gotoff SP (1985) Strategies for chemoprophylaxis of GBS early-onset infections. Antibiot Chemother 35:267–280

    PubMed  CAS  Google Scholar 

  19. 19.

    Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A (2002) Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 51:1–22

    PubMed  Google Scholar 

  20. 20.

    Ancona RJ, Ferrieri P, Williams PP (1980) Maternal factors that enhance the acquisition of group-B streptococci by newborn infants. J Med Microbiol 13:273–280

    PubMed  Article  CAS  Google Scholar 

  21. 21.

    Boyer KM, Gadzala CA, Kelly PD, Burd LI, Gotoff SP (1983) Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures. J Infect Dis 148:802–809

    PubMed  Article  CAS  Google Scholar 

  22. 22.

    Slotved HC, Kong F, Lambertsen L, Sauer S, Gilbert GL (2007) Serotype IX, a proposed new Streptococcus agalactiae serotype. J Clin Micobiol 45:2929–2936

    Article  CAS  Google Scholar 

  23. 23.

    Rajagopal L (2009) Understanding the regulation of group B streptococcal virulence factors. Future Microbiol 4:201–221

    PubMed  Article  CAS  Google Scholar 

  24. 24.

    Baker CJ, Kasper DL (1976) Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med 294:753–756

    PubMed  Article  CAS  Google Scholar 

  25. 25.

    Zangwill KM, Schuchat A, Wenger JD (1992) Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. MMWR CDC Surveill Summ 41:25–32

    PubMed  CAS  Google Scholar 

  26. 26.

    Centers for Disease Control and Prevention (CDC) (1997) Decreasing Incidence of perinatal group B streptococcal disease—United States, 1993–1995. MMWR Morb Mortal Wkly Rep 46:473–477

    Google Scholar 

  27. 27.

    Mayon-White RT (1985) The Incidence of GBS disease in neonates in different countries. Antibiot Chemother 35:17–27

    PubMed  CAS  Google Scholar 

  28. 28.

    Kalliola S, Vuopio-Varkila J, Takala AK, Eskola J (1999) Neonatal group B streptococcal disease in Finland: a ten-year nationwide study. Pediatr Infect Dis J 18:806–810

    PubMed  Article  CAS  Google Scholar 

  29. 29.

    Poulain P, Betremieux P, Donnio PY, Proudhon JF, Karege G, Giraud JR (1997) Selective intrapartum anti-bioprophylaxy of group B streptococci infection of neonates: a prospective study in 2454 subsequent deliveries. Eur J Obstet Gynecol Reprod Biol 72:137–140

    PubMed  Article  CAS  Google Scholar 

  30. 30.

    Jourdan-Da Silva N, Antona D, Six C, Georges S, Goulet V, Judlin P, Lévy-Bruhl D (2008) Neonatal group B streptococcus infections in France: incidence from 1997 to 2006 and current prevention practices in maternity wards. Bull Epidemiol Hebd 14:110–113

    Article  Google Scholar 

  31. 31.

    Simetka O, Petros M, Podesvová H (2010) Prevention of early-onset neonatal group B streptococcal infection: neonatal outcome after introduction of national screening guideline. Ceska Gynekol 75:41–46

    PubMed  CAS  Google Scholar 

  32. 32.

    López Sastre JB, Coto Cotallo GD, Fernández Colomer B; Grupo de Hospitales Castrillo (2009) Neonatal sepsis of vertical transmission: an epidemiological study from the “Grupo de Hospitales Castrillo”. J Perinat Med 28:309–315

    Article  Google Scholar 

  33. 33.

    Boyer KM, Gotoff SP (1986) Prevention of early-onset neonatal Group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 314:1665–1669

    PubMed  Article  CAS  Google Scholar 

  34. 34.

    Benitz WE, Gould JB, Druzin ML (1999) Antimicrobial prevention of early-onset group B streptococcal sepsis: estimates of risk reduction based on a critical literature review. Pediatrics 103:e78

    PubMed  Article  CAS  Google Scholar 

  35. 35.

    Vergnano S, Embleton N, Collinson A, Menson E, Russell AB, Heath P (2010) Missed opportunities for preventing group B streptococcus infection. Arch Dis Child Fetal Neonatal Ed 95:F72–F73

    PubMed  Article  CAS  Google Scholar 

  36. 36.

    Centers for Disease Control and Prevention (CDC) (2009) Trends in perinatal group B streptococcal disease—United States, 2000–2006. MMWR Morb Mortal Wkly Rep 58:109–112

    Google Scholar 

  37. 37.

    Gardner SE, Yow MD, Leeds LJ, Thompson PK, Mason EO Jr, Clark DJ (1979) Failure of penicillin to eradicate group B streptococcal colonization in the pregnant woman. A couple study. Am J Obstet Gynecol 135:1062–1065

    PubMed  CAS  Google Scholar 

  38. 38.

    Gibbs RS, Hall RT, Yow MD, McCracken GH Jr, Nelson JD (1992) Consensus: perinatal prophylaxis for group B streptococcal infection. Pediatr Infect Dis J 11:179–183

    PubMed  Article  CAS  Google Scholar 

  39. 39.

    Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, Craig AS, Schaffner W, Zansky SM, Gershman K, Stefonek KR, Albanese BA, Zell ER, Schuchat A, Schrag SJ; Active Bacterial Core surveillance/Emerging Infections Program Network (2008) Epidemiology of invasive group B streptococcal disease in the United States, 1999–2005. JAMA 299:2056–2065

    PubMed  Article  CAS  Google Scholar 

  40. 40.

    Società Italiana di Medicina Perinatale (1996) Proposta: linee-guida per la prevenzione delle infezioni perinatali da streptococco β-emolitico di gruppo B. Boll Soc Ital Med Perinatale 1:21–24

    Google Scholar 

  41. 41.

    Sociedad Española de Obstetricia y Ginecología (1998) Recomendaciones para la prevención de la infección perinatal por estreptococo del grupo B. Prog Obstet Gynecol 41:431–435

    Google Scholar 

  42. 42.

    Sociedades Españolas de Obstetricia y Ginecología, Neonatología, Enfermedades Infecciosas y Microbiología Clínica, Quimioterapia, Medicina Familiar y Comunitaria (2003) Prevención de la infección perinatal por estreptococo del grupo B. Recomendaciones españolas revisadas. Enferm Infecc Microbiol Clin 21:417–423

    Article  Google Scholar 

  43. 43.

    Agence Nationale d’Accreditation et d’Evaluation en Santé (2001) Prévention anténatale du risque infectieux bactérien néonatal précoce. Available online at: http://www.has-sante.fr/portail/jcms/c_272118/prevention-antenatale-du-risque-infectieux-bacterien-neonatal-precoce Accessed 29 December 2011

  44. 44.

    Leitlinien der Gesellschaft für Neonatologie und Pädiatrische Intensivmedizin (GNPI), Deutschen Gesellschaft für Gynäkologie und Geburtshilfe, Deutschen Gesellschaft für Pädiatrische Infektiologie (DGPI), und Deutsche Gesellschaft für Perinatale Medizin (DGPM) (2008) Prophylaxe der neugeborenensepsis (frühe form) durch streptokokken der gruppe B. Available online at: http://www.uni-duesseldorf.de/AWMF/ll/024-020.htm. Accessed 28 December 2011

  45. 45.

    Kommission für Qualitätssicherung der Schweizerischen Gesellschaft für Gynäkologie und Geburtshilfe (2007) Prophylaxe der frühen neugeborenensepsis durch streptokokken der gruppe B. Gynäkol Geburtshilfliche Rundsch 47:103–104

    Article  Google Scholar 

  46. 46.

    Měchurová A, Unzeitig V, Vlk R (2008) Doporučené postupy V perinatologii 3. Doporučený postup při diagnostice a léčbě streptokoků skupiny B v těhotenství a za porodu. Moderní Gynekologii Porodnictví 16:45–48

    Google Scholar 

  47. 47.

    Belgium Health Council (2003) Prevention of perinatal streptococcal infections. Guidelines from the Belgian Health Council. Available online at: https://portal.health.fgov.be/pls/portal/docs/PAGE/INTERNET_PG/HOMEPAGE_MENU/ABOUTUS1_MENU/INSTITUTIONSAPPARENTEES1_MENU/HOGEGEZONDHEIDSRAAD1_MENU/ADVIEZENENAANBEVELINGEN1_MENU/ADVIEZENENAANBEVELINGEN1_DOCS/7721%20GBS_EN%202003.PDF. Accessed 28 December 2011

  48. 48.

    Kotarski J, Heczko PB, Lauterbach R, Niemiec T, Leszczyńska-Gorzelak B (2008) Rekomendacje polskiego towarzystwa ginekologicznego dotyczące wykrywania nosicielstwa paciorkowców grupy B (GBS) u kobiet w ciąży i zapobiegania zakażeniom u noworodków. Ginekol Pol 79:221–223

    PubMed  Google Scholar 

  49. 49.

    Nederlandse Vereniging voor Obstetrie en Gynaecologie (NVOG) (2008) Preventie van neonatale groep-B-streptokokkenziekte (GBS-Ziekte). Versie 2.0. Available online at: http://www.nvog-documenten.nl/richtlijn/item/pagina.php?id=26959&richtlijn_id=827. Accessed 28 December 2011

  50. 50.

    Royal College of Obstetricians and Gynaecologists (2003) RCOG Guideline No. 36. Prevention of early onset neonatal group B streptococcal disease. Available online at: http://www.rcog.org.uk/files/rcog-corp/uploaded-files/GT36GroupBStrep2003.pdf. Accessed 28 December 2011

  51. 51.

    Campbell N, Eddy A, Darlow B, Stone P, Grimwood K; New Zealand GBS Consensus Working Party (2004) The prevention of early-onset neonatal group B streptococcus infection: technical report from the New Zealand GBS Consensus Working Party. N Z Med J 117(1200):U1023

    PubMed  Google Scholar 

  52. 52.

    Daley AJ, Isaacs D; Australasian Study Group for Neonatal Infections (2004) Ten-year study on the effect of intrapartum antibiotic prophylaxis on early onset group B streptococcal and Escherichia coli neonatal sepsis in Australasia. Pediatr Infect Dis J 23:630–634

    PubMed  Article  Google Scholar 

  53. 53.

    Weston EJ, Pondo T, Lewis MM, Martell-Cleary P, Morin C, Jewell B, Daily P, Apostol M, Petit S, Farley M, Lynfield R, Reingold A, Hansen NI, Stoll BJ, Shane AJ, Zell E, Schrag SJ (2011) The burden of invasive early-onset neonatal sepsis in the United States, 2005–2008. Pediatr Infect Dis J 30:937–941

    PubMed  Article  Google Scholar 

  54. 54.

    Dahl MS, Tessin I, Trollfors B (2003) Invasive group B streptococcal infections in Sweden: incidence, predisposing factors and prognosis. Int J Infect Dis 7:113–119

    PubMed  Article  Google Scholar 

  55. 55.

    Lyytikäinen O, Nuorti JP, Halmesmäki E, Carlson P, Uotila J, Vuento R, Ranta T, Sarkkinen H, Ámmälä M, Kostiala A, Järvenpää AL (2003) Invasive group B streptococcal infections in Finland: a population-based study. Emerg Infect Dis 9:469–473

    PubMed  Article  Google Scholar 

  56. 56.

    Andersen J, Christensen R, Hertel J (2004) Clinical features and epidemiology of septicaemia and meningitis in neonates due to Streptococcus agalactiae in Copenhagen county, Denmark: a 10 year survey from 1992 to 2001. Acta Paediatr 93:1334–1339

    PubMed  Article  CAS  Google Scholar 

  57. 57.

    Fluegge K, Siedler A, Heinrich B, Schulte-Moenting J, Moennig MJ, Bartels DB, Dammann O, Von Kries R, Berner R; German Pediatric Surveillance Unit Study Group (2006) Incidence and clinical presentation of invasive neonatal group B streptococcal infections in Germany. Pediatrics 117:e1139–e1145

    PubMed  Article  Google Scholar 

  58. 58.

    Neto MT (2008) Group B streptococcal disease in Portuguese infants younger than 90 days. Arch Dis Child Fetal Neonatal Ed 93:F90–F93

    PubMed  Article  CAS  Google Scholar 

  59. 59.

    Poyart C, Réglier-Poupet H, Tazi A, Billoët A, Dmytruk N, Bidet P, Bingen E, Raymond J, Trieu-Cuot P (2008) Invasive group B streptococcal infections in infants, France. Emerg Infect Dis 14:1647–1649

    PubMed  Article  Google Scholar 

  60. 60.

    Bergseng H, Rygg M, Bevanger L, Bergh K (2008) Invasive group B streptococcus (GBS) disease in Norway 1996–2006. Eur J Clin Microbiol Infect Dis 27:1193–1199

    PubMed  Article  CAS  Google Scholar 

  61. 61.

    Berardi A, Lugli L, Baronciani D, Rossi C, Ciccia M, Creti R, Gambini L, Mariani S, Papa I, Tridapalli E, Vagnarelli F, Ferrari F; GBS Prevention Working Group of Emilia-Romagna (2010) Group B streptococcus early-onset disease in Emilia-Romagna: review after Introduction of a screening-based approach. Pediatr Infect Dis J 29:115–121

    PubMed  Article  Google Scholar 

  62. 62.

    Doit C, Mariani-Kurkdjian P, Mahjoub-Messai F, Bidet P, Bonacorsi S, Carol A, Varon E, Bingen E (2010) Epidemiology of pediatric community-acquired bloodstream infections in a children hospital in Paris, France, 2001 to 2008. Diagn Microbiol Infect Dis 66:332–335

    PubMed  Article  Google Scholar 

  63. 63.

    Berardi A, Lugli L, Baronciani D, Creti R, Rossi K, Ciccia M, Gambini L, Mariani S, Papa I, Serra L, Tridapalli E, Ferrari F; GBS Prevention Working Group of Emilia-Romagna (2007) Group B streptococcal infections in a northern region of Italy. Pediatrics 120:e487–e493

    PubMed  Article  Google Scholar 

  64. 64.

    Lancefield RC (1938) Two serological types of group B hemolytic streptococci with related, but not identical, type-specific substances. J Exp Med 67:25–40

    PubMed  Article  CAS  Google Scholar 

  65. 65.

    Baker CJ, Edwards MS, Kasper DL (1981) Role of antibody to native type III polysaccharide of group B streptococcus in infant infection. Pediatrics 68:544–549

    PubMed  CAS  Google Scholar 

  66. 66.

    Baker CJ (1990) Immunization to prevent group B streptococcal disease: victories and vexations. J Infect Dis 161:917–921

    PubMed  Article  CAS  Google Scholar 

  67. 67.

    Prieto Tato LM, Gimeno Díaz de Atauri A, Aracil Santos J, Omeñaca Teres F, del Castillo MF, de José Gómez MI (2008) Infección tardía por estreptococo del grupo B: experiencia en un hospital de tercer nivel (2000–2006). An Pediatr (Barc) 68:239–243

    Article  CAS  Google Scholar 

  68. 68.

    Farley MM (2001) Group B streptococcal disease in nonpregnant adults. Clin Infect Dis 33:556–561

    PubMed  Article  CAS  Google Scholar 

  69. 69.

    Lin FY, Weisman LE, Azimi PH, Philips JB 3rd, Clark P, Regan J, Rhoads GG, Frasch CE, Gray BM, Troendle J, Brenner RA, Moyer P, Clemens JD (2004) Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen. J Infect Dis 190:928–934

    PubMed  Article  CAS  Google Scholar 

  70. 70.

    DEVANI. Vaccine against neonatal infections. Home page at: http://www.devaniproject.org/. Accessed 28 December 2011

  71. 71.

    Heath PT (2011) An update on vaccination against group B streptococcus. Expert Rev Vaccines 10:685–694

    PubMed  Article  Google Scholar 

  72. 72.

    Melin P (2011) Neonatal group B streptococcal disease: from pathogenesis to preventive strategies. Clin Microbiol Infect 17:1294–1303

    PubMed  CAS  Google Scholar 

  73. 73.

    Johri AK, Paoletti LC, Glaser P, Dua M, Sharma PK, Grandi G, Rappuoli R (2006) Group B streptococcus: global incidence and vaccine development. Nat Rev Microbiol 4:932–942

    PubMed  Article  CAS  Google Scholar 

  74. 74.

    World Health Organization (WHO) (2005) State of the art of vaccine research and development: initiative for vaccine research. Available online at: http://www.who.int/vaccine_research/documents/Dip%20814.pdf. Accessed 28 December 2011

  75. 75.

    Afshar B, Broughton K, Creti R, Decheva A, Hufnagel M, Kriz P, Lambertsen L, Lovgren M, Melin P, Orefici G, Poyart C, Radtke A, Rodriguez-Granger J, Sørensen UB, Telford J, Valinsky L, Zachariadou L; Members of the DEVANI Study Group, Efstratiou A (2011) International external quality assurance for laboratory identification and typing of Streptococcus agalactiae (group B streptococci). J Clin Microbiol 49:1475–1482

    PubMed  Article  CAS  Google Scholar 

  76. 76.

    Berardi A, Di Fazzio G, Gavioli S, Di Grande E, Groppi A, Papa I, Piccinini G, Simoni A, Tridapalli E, Volta A, Facchinetti F, Ferrari F; GBS Prevention Working Group, Emilia-Romagna (2011) Universal antenatal screening for group B streptococcus in Emilia-Romagna. J Med Screen 18:60–64

    PubMed  Article  Google Scholar 

  77. 77.

    Bedford Russell AR, Breathnach A, Sender P (2001) Confirmed group B streptococcus infection: the tip of the iceberg. Arch Dis Child Fetal Neonatal Ed 84:F140

    PubMed  Article  CAS  Google Scholar 

  78. 78.

    Carbonell-Estrany X, Figueras-Aloy J, Salcedo-Abizanda S, de la Rosa-Fraile M; Castrillo Study Group (2008) Probable early-onset group B streptococcal neonatal sepsis: a serious clinical condition related to intrauterine infection. Arch Dis Child Fetal Neonatal Ed 93:F85–F89

    PubMed  Article  CAS  Google Scholar 

  79. 79.

    Terrone DA, Rinehart BK, Einstein MH, Britt LB, Martin JN Jr, Perry KG (1999) Neonatal sepsis and death caused by resistant Escherichia coli: possible consequences of extended maternal ampicillin administration. Am J Obstet Gynecol 180:1345–1348

    PubMed  Article  CAS  Google Scholar 

  80. 80.

    Moore MR, Schrag SJ, Schuchat A (2003) Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. Lancet Infect Dis 3:201–213

    PubMed  Article  Google Scholar 

  81. 81.

    Schrag SJ, Hadler JL, Arnold KE, Martell-Cleary P, Reingold A, Schuchat A (2006) Risk factors for invasive, early-onset Escherichia coli infections in the era of widespread intrapartum antibiotic use. Pediatrics 118:570–6

    PubMed  Article  Google Scholar 

  82. 82.

    Schrag SJ, Stoll BJ (2006) Early-onset neonatal sepsis in the era of widespread intrapartum chemoprophylaxis. Pediatr Infect Dis J 25:939–940

    PubMed  Article  Google Scholar 

  83. 83.

    Spaetgens R, DeBella K, Ma D, Robertson S, Mucenski M, Davies HD (2002) Perinatal antibiotic usage and changes in colonization and resistance rates of group B streptococcus and other pathogens. Obstet Gynecol 100:525–533

    PubMed  Article  Google Scholar 

  84. 84.

    Betreuung der Neugeborenen von Müttern, die mit Streptokokken der Gruppe B kolonisiert sind. Empfehlungen der Schweizerischen Gesellschaft für Neonatologie (2007) Available online at: http://www.gfmer.ch/Guidelines/Neonatologie_d/Neonatologie_mt.htm. Accessed 28 December 2011

  85. 85.

    Isaacs D (1998) Prevention of early onset group B streptococcal infection: screen, treat, or observe? Arch Dis Child Fetal Neonatal Ed 79:F81–F82

    PubMed  Article  CAS  Google Scholar 

  86. 86.

    Colbourn TE, Asseburg C, Bojke L, Philips Z, Welton NJ, Claxton K, Ades AE, Gilbert RE (2007) Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses. BMJ 335:655

    PubMed  Article  Google Scholar 

  87. 87.

    UK, Group B Strep Support. Home page at: http://www.gbss.org.uk/. Accessed 28 December 2011

  88. 88.

    Netherlands, Dutch Foundation GBS. Home page at: http://www.ogbs.nl/. Accessed 28 December 2011

  89. 89.

    USA, Group B Strep Association. Home page at: http://GroupBStrep.org/. Accessed 28 December 2011

  90. 90.

    Argentina, Prevencionegb. Home page at: http://www.pacientesonline.org/medicina/protagonistas/prevencionegb.php. Accessed 28 December 2011

  91. 91.

    Canada, Strep B Foundation. Home page at: http://www.strepb.ca/. Accessed 24 May 2011

  92. 92.

    Eickhoff TC, Klein JO, Daly AK, Ingall D, Finland M (1964) Neonatal sepsis and other infections due to group B β-hemolytic streptococci. N Engl J Med 271:1221–1228

    PubMed  Article  CAS  Google Scholar 

  93. 93.

    Deutchman M (1998) Thoughts on the prevention of neonatal group B streptococcal infection. Am Fam Physician 57:2602–2606

    PubMed  CAS  Google Scholar 

  94. 94.

    de la Rosa Fraile M, Cabero L, Andreu A, Rao GG (2001) Prevention of group B streptococcal neonatal disease: a plea for a European consensus. Clin Microbiol Infect 7:25–27

    PubMed  Article  Google Scholar 

Download references

Acknowledgments

The DEVANI consortium is funded by European Commission (EC) in the frame of the Seventh Framework Programme (FP7), HEALTH-F5-2007-200481.

The researchers are not dependent on the founder.

Author information

Affiliations

Authors

Corresponding author

Correspondence to J. Rodriguez-Granger.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Rodriguez-Granger, J., Alvargonzalez, J.C., Berardi, A. et al. Prevention of group B streptococcal neonatal disease revisited. The DEVANI European project. Eur J Clin Microbiol Infect Dis 31, 2097–2104 (2012). https://doi.org/10.1007/s10096-012-1559-0

Download citation

Keywords

  • Intrapartum Antibiotic Prophylaxis